Richard Rosenblum
President at INNOVATIVE PAYMENT SOLUTIONS, INC.
Net worth: 18 667 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
William Corbett | M | 65 | 5 years | |
William E. Horne | M | 70 | 6 years | |
Michael Yurkowsky | M | 53 | 5 years | |
Federico Pier | M | 56 | 15 years | |
Raymond Monteleone | M | 77 | 5 years | |
David Rios | M | 81 | 3 years | |
Jeffery Wright | M | 41 | 5 years | |
Jeremy Daniel | M | 48 | 5 years | |
Tanya Rhodes | M | 64 | 4 years | |
Matthew Anderer | M | 59 | 2 years | |
Charles Farrahar | M | 63 | 2 years | |
Colleen Delaney | M | 57 | 2 years | |
Dorothy Jordan | M | 67 | - | |
Jason Assad | M | - | - | |
Yulia Rey | F | - | - | |
Maria Taktarov | F | - | - | |
Madisson Butler | F | 34 | 3 years | |
Stephanie Simpson | F | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Dave Stefansky | M | 52 |
Boxwoods, Inc.
Boxwoods, Inc. Financial ConglomeratesFinance The Company is currently an inactive company seeking merger and business operations opportunities. On 27-Oct-2006, the Company ceased operations, and discontinued all business activities.
HG Partners, Inc.
HG Partners, Inc. Financial ConglomeratesFinance HG Partners, Inc. provides commercial and residential installation and maintenance (HVAC) services in the heating, ventilation, and air conditioning industry. The company was founded in January 2006 and is headquartered in Pearland, TX.
Marine Park Holdings, Inc.
Mill Basin Technologies, Ltd.
Mobile Reach International, Inc.
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011.
Harborview Capital Management LLC
Harborview Capital Management LLC Investment ManagersFinance Harborview Capital Management LLC (Harborview) is an independent hedge fund manager headquartered in New York City. The firm was founded by David “Dave” Stefansky in 2004. Harborview manages the assets of high-net-worth clients.
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 9 years |
Steven C. Berger | M | 63 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011.
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA.
Harborview Capital Management LLC
Harborview Capital Management LLC Investment ManagersFinance Harborview Capital Management LLC (Harborview) is an independent hedge fund manager headquartered in New York City. The firm was founded by David “Dave” Stefansky in 2004. Harborview manages the assets of high-net-worth clients. | 3 years |
Brian Posner | M | 62 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 5 years |
Amit Singh Dang | M | 43 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | 1 years |
Andrey Novikov | M | 54 | 5 years | |
David Ian Johnson | M | 66 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | - |
Jerome Zeldis | M | 74 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 5 years |
Nachum Stein | M | 75 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011.
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 1 years |
Mike M. Goldberg | M | 65 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011.
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 1 years |
Kenneth D. Pearsen | M | 63 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011.
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 3 years |
Joseph M. Leone | M | 70 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011.
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | - |
Jeffrey Sklar | M | 61 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011.
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | - |
James Fuller | M | 84 | 5 years | |
Douglas Reif | M | 70 |
State University of New York at Buffalo
| 6 years |
David A. Dooley | M | - |
State University of New York at Buffalo
| 5 years |
James Daly | M | 63 |
State University of New York at Buffalo
| 6 years |
Paul S. Molnar | M | 68 |
State University of New York at Buffalo
| 6 years |
Neil Leibman | M | 64 |
State University of New York at Buffalo
| 4 years |
Harold C. Smith | M | - |
State University of New York at Buffalo
| 5 years |
Gary P. Jacobi | M | - |
State University of New York at Buffalo
| 5 years |
Harry Patrick Barnum | M | - |
State University of New York at Buffalo
| 5 years |
Kenneth Londoner | M | 57 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 2 years |
Clifford Henry | M | 85 | 2 years | |
Glenn Henrickson | M | - |
State University of New York at Buffalo
| 5 years |
Joseph Sierchio | M | 74 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA.
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | 4 years |
James Sapirstein | M | 63 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 2 years |
Kevin Centofanti | M | 64 |
State University of New York at Buffalo
| 6 years |
Calvin J. Puffer | M | - |
State University of New York at Buffalo
| 2 years |
Eric Lynn | M | - |
State University of New York at Buffalo
| 4 years |
Howard A. Werman | M | - |
State University of New York at Buffalo
| 3 years |
Jamilus bin Mohamed Hussin | M | 80 |
State University of New York at Buffalo
| 1 years |
Harvey L. Kaminski | M | - |
State University of New York at Buffalo
| 3 years |
W. Anthony Sandonato | M | - |
State University of New York at Buffalo
| 4 years |
Stuart Loewenstein | M | 64 |
State University of New York at Buffalo
| 4 years |
Philip Francis Rongo | M | 62 |
State University of New York at Buffalo
| 4 years |
Bradford C. Barton | M | 64 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 5 years |
Jim Badke | M | - |
State University of New York at Buffalo
| 4 years |
Lewis I. Goldman | M | - |
State University of New York at Buffalo
| 3 years |
Kevin Russell Orr | M | - |
State University of New York at Buffalo
| 4 years |
Brent M. Brothers | M | - |
HG Partners, Inc.
HG Partners, Inc. Financial ConglomeratesFinance HG Partners, Inc. provides commercial and residential installation and maintenance (HVAC) services in the heating, ventilation, and air conditioning industry. The company was founded in January 2006 and is headquartered in Pearland, TX. | - |
Joseph Laudano | M | - |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | - |
Deborah B. O’Shea | F | - |
State University of New York at Buffalo
| 3 years |
John Brodfuehrer | M | 66 |
State University of New York at Buffalo
| 4 years |
Bob Schorr | M | - |
State University of New York at Buffalo
| 3 years |
Perry Edward Atkins | M | - |
State University of New York at Buffalo
| 4 years |
Eric Darvin | M | - |
State University of New York at Buffalo
| 4 years |
Tony Ogorek | M | - |
State University of New York at Buffalo
| 1 years |
Sunny Chukwudi Obidegwu | M | - |
State University of New York at Buffalo
| 4 years |
Steven Cohen | M | - |
State University of New York at Buffalo
| 4 years |
Jeffrey Thompson | M | - |
HG Partners, Inc.
HG Partners, Inc. Financial ConglomeratesFinance HG Partners, Inc. provides commercial and residential installation and maintenance (HVAC) services in the heating, ventilation, and air conditioning industry. The company was founded in January 2006 and is headquartered in Pearland, TX. | - |
Michael Calise | M | - |
State University of New York at Buffalo
| 4 years |
Perry Karsen | M | 69 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 3 years |
Todd N. Tipton | M | 67 |
State University of New York at Buffalo
| 4 years |
Jordan Levy | M | 68 |
State University of New York at Buffalo
| 4 years |
Andrew B. Rosengard | M | - |
State University of New York at Buffalo
| 4 years |
Robert Black | M | 65 |
State University of New York at Buffalo
| 4 years |
Harold Meckler | M | - |
State University of New York at Buffalo
| 3 years |
Francis J. Boggan | M | - |
State University of New York at Buffalo
| 4 years |
Richard Gluck | M | - |
State University of New York at Buffalo
| 4 years |
Curt Launer | M | 68 |
State University of New York at Buffalo
| 4 years |
David Oppenheimer | M | 67 |
State University of New York at Buffalo
| 4 years |
Jim Ferrare | M | - |
State University of New York at Buffalo
| 4 years |
Rod A. Ferguson | M | 67 |
State University of New York at Buffalo
| 3 years |
Alan H. Solarz | M | - |
State University of New York at Buffalo
| 3 years |
Chi K. Eng | M | 64 |
State University of New York at Buffalo
| 4 years |
Joseph I. Rader | M | - |
State University of New York at Buffalo
| 4 years |
Jules Ringer | M | - |
Duke Mining Co., Inc.
Duke Mining Co., Inc. Precious MetalsNon-Energy Minerals Duke Mining Company, Inc. is focused on mining, processing and exploring for gold and other metals in the western United States. The Company owns a gold mine known as The Duke Mine situated in Southeast Utah. On March 26, 2009, Harborview Master Fund, L.P., Boxwoods, Inc. and Duke Mining Acquisition LLC entered into an agreement. Pursuant to the agreement Harborview transferred its interest in Duke to Duke Acquisition. The company is headquartered in New York, NY. | - |
Darren L. Miles | M | 65 |
Boxwoods, Inc.
Boxwoods, Inc. Financial ConglomeratesFinance The Company is currently an inactive company seeking merger and business operations opportunities. On 27-Oct-2006, the Company ceased operations, and discontinued all business activities. | - |
James M. Craig | M | 67 |
State University of New York at Buffalo
| 4 years |
Peter Jerome Grogan | M | - |
State University of New York at Buffalo
| 3 years |
Keith S. Barton | M | - |
Mill Basin Technologies, Ltd.
| - |
Michelle M. Barton | F | - |
Mill Basin Technologies, Ltd.
| - |
Hoi Sing Kwok | M | 73 |
State University of New York at Buffalo
| 12 years |
Jack Ross | M | 67 |
State University of New York at Buffalo
| 4 years |
Tim Forhan | M | - |
State University of New York at Buffalo
| 2 years |
Marc E. Shapiro | M | 67 |
State University of New York at Buffalo
| 4 years |
Robert Blair | M | 81 |
Marine Park Holdings, Inc.
| 1 years |
Shelley Bergman | F | - |
State University of New York at Buffalo
| 3 years |
Joe Frandina | M | - |
State University of New York at Buffalo
| 4 years |
John S. Malanowski | M | - |
State University of New York at Buffalo
| 4 years |
Stephen L. Giroux | M | - |
State University of New York at Buffalo
| 4 years |
Robert Gaffney | M | - |
State University of New York at Buffalo
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Rosenblum
- Personal Network